nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS1—kidney cancer	0.257	0.636	CbGaD
Meloxicam—PTGS2—kidney cancer	0.147	0.364	CbGaD
Meloxicam—ABCC4—Sorafenib—kidney cancer	0.0572	0.167	CbGbCtD
Meloxicam—ABCC4—Sunitinib—kidney cancer	0.0464	0.136	CbGbCtD
Meloxicam—CYP3A4—Everolimus—kidney cancer	0.0323	0.0944	CbGbCtD
Meloxicam—CYP2C8—Pazopanib—kidney cancer	0.0282	0.0826	CbGbCtD
Meloxicam—CYP3A4—Temsirolimus—kidney cancer	0.0218	0.0638	CbGbCtD
Meloxicam—CYP2C9—Capecitabine—kidney cancer	0.0206	0.0601	CbGbCtD
Meloxicam—CYP2C8—Erlotinib—kidney cancer	0.0202	0.0589	CbGbCtD
Meloxicam—CYP2C8—Paclitaxel—kidney cancer	0.0185	0.054	CbGbCtD
Meloxicam—CYP2C8—Sorafenib—kidney cancer	0.0164	0.0479	CbGbCtD
Meloxicam—CYP2C9—Paclitaxel—kidney cancer	0.0129	0.0376	CbGbCtD
Meloxicam—CYP3A4—Pazopanib—kidney cancer	0.0115	0.0335	CbGbCtD
Meloxicam—CYP2C9—Sorafenib—kidney cancer	0.0114	0.0334	CbGbCtD
Meloxicam—CYP3A4—Erlotinib—kidney cancer	0.00817	0.0239	CbGbCtD
Meloxicam—CYP3A4—Paclitaxel—kidney cancer	0.00748	0.0219	CbGbCtD
Meloxicam—CYP3A4—Sorafenib—kidney cancer	0.00665	0.0194	CbGbCtD
Meloxicam—CYP3A4—Vinblastine—kidney cancer	0.00656	0.0192	CbGbCtD
Meloxicam—CYP3A4—Vincristine—kidney cancer	0.00645	0.0189	CbGbCtD
Meloxicam—CYP3A4—Sunitinib—kidney cancer	0.00539	0.0157	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—kidney cancer	0.00403	0.0118	CbGbCtD
Meloxicam—PTGS2—nephron—kidney cancer	0.00224	0.115	CbGeAlD
Meloxicam—CYP2C9—urine—kidney cancer	0.00206	0.106	CbGeAlD
Meloxicam—CYP3A4—urine—kidney cancer	0.00157	0.0808	CbGeAlD
Meloxicam—PGD—nephron tubule—kidney cancer	0.00121	0.0622	CbGeAlD
Meloxicam—PGD—renal system—kidney cancer	0.0011	0.0565	CbGeAlD
Meloxicam—PGD—kidney—kidney cancer	0.00106	0.0547	CbGeAlD
Meloxicam—Lornoxicam—PTGS1—kidney cancer	0.00104	0.261	CrCbGaD
Meloxicam—PGD—cortex of kidney—kidney cancer	0.00104	0.0532	CbGeAlD
Meloxicam—PGD—gonad—kidney cancer	0.000987	0.0507	CbGeAlD
Meloxicam—PGD—cardiac atrium—kidney cancer	0.000985	0.0506	CbGeAlD
Meloxicam—Tenoxicam—PTGS1—kidney cancer	0.000931	0.232	CrCbGaD
Meloxicam—ABCC4—nephron tubule—kidney cancer	0.000861	0.0442	CbGeAlD
Meloxicam—ABCC4—renal system—kidney cancer	0.000783	0.0402	CbGeAlD
Meloxicam—ABCC4—kidney—kidney cancer	0.000757	0.0389	CbGeAlD
Meloxicam—ABCC4—cortex of kidney—kidney cancer	0.000737	0.0379	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—kidney cancer	0.000597	0.149	CrCbGaD
Meloxicam—Piroxicam—PTGS1—kidney cancer	0.000575	0.143	CrCbGaD
Meloxicam—CYP2C8—renal system—kidney cancer	0.000568	0.0292	CbGeAlD
Meloxicam—CYP2C8—kidney—kidney cancer	0.000549	0.0282	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—kidney cancer	0.000532	0.133	CrCbGaD
Meloxicam—PTGS1—renal system—kidney cancer	0.000461	0.0237	CbGeAlD
Meloxicam—PTGS1—kidney—kidney cancer	0.000445	0.0229	CbGeAlD
Meloxicam—PTGS2—renal system—kidney cancer	0.00044	0.0226	CbGeAlD
Meloxicam—PTGS2—kidney—kidney cancer	0.000426	0.0219	CbGeAlD
Meloxicam—PTGS1—cardiac atrium—kidney cancer	0.000413	0.0212	CbGeAlD
Meloxicam—CYP3A4—renal system—kidney cancer	0.000385	0.0198	CbGeAlD
Meloxicam—CYP3A4—kidney—kidney cancer	0.000372	0.0191	CbGeAlD
Meloxicam—Piroxicam—PTGS2—kidney cancer	0.000329	0.082	CrCbGaD
Meloxicam—Confusional state—Paclitaxel—kidney cancer	6.86e-05	0.000364	CcSEcCtD
Meloxicam—Blood creatinine increased—Doxorubicin—kidney cancer	6.86e-05	0.000364	CcSEcCtD
Meloxicam—Erythema—Capecitabine—kidney cancer	6.84e-05	0.000363	CcSEcCtD
Meloxicam—Malnutrition—Capecitabine—kidney cancer	6.84e-05	0.000363	CcSEcCtD
Meloxicam—Dehydration—Doxorubicin—kidney cancer	6.81e-05	0.000362	CcSEcCtD
Meloxicam—Anaphylactic shock—Paclitaxel—kidney cancer	6.8e-05	0.000361	CcSEcCtD
Meloxicam—Oedema—Paclitaxel—kidney cancer	6.8e-05	0.000361	CcSEcCtD
Meloxicam—Abdominal pain—Vincristine—kidney cancer	6.77e-05	0.00036	CcSEcCtD
Meloxicam—Body temperature increased—Vincristine—kidney cancer	6.77e-05	0.00036	CcSEcCtD
Meloxicam—Liver function test abnormal—Doxorubicin—kidney cancer	6.76e-05	0.000359	CcSEcCtD
Meloxicam—Infection—Paclitaxel—kidney cancer	6.76e-05	0.000359	CcSEcCtD
Meloxicam—Flatulence—Capecitabine—kidney cancer	6.74e-05	0.000358	CcSEcCtD
Meloxicam—Dysgeusia—Capecitabine—kidney cancer	6.7e-05	0.000356	CcSEcCtD
Meloxicam—Dizziness—Sunitinib—kidney cancer	6.69e-05	0.000356	CcSEcCtD
Meloxicam—Feeling abnormal—Gemcitabine—kidney cancer	6.69e-05	0.000356	CcSEcCtD
Meloxicam—Shock—Paclitaxel—kidney cancer	6.69e-05	0.000356	CcSEcCtD
Meloxicam—Vomiting—Sorafenib—kidney cancer	6.69e-05	0.000356	CcSEcCtD
Meloxicam—Abdominal pain upper—Doxorubicin—kidney cancer	6.68e-05	0.000355	CcSEcCtD
Meloxicam—Nervous system disorder—Paclitaxel—kidney cancer	6.67e-05	0.000355	CcSEcCtD
Meloxicam—Thrombocytopenia—Paclitaxel—kidney cancer	6.66e-05	0.000354	CcSEcCtD
Meloxicam—Tachycardia—Paclitaxel—kidney cancer	6.64e-05	0.000353	CcSEcCtD
Meloxicam—Rash—Sorafenib—kidney cancer	6.63e-05	0.000353	CcSEcCtD
Meloxicam—Dermatitis—Sorafenib—kidney cancer	6.63e-05	0.000352	CcSEcCtD
Meloxicam—Back pain—Capecitabine—kidney cancer	6.61e-05	0.000352	CcSEcCtD
Meloxicam—Skin disorder—Paclitaxel—kidney cancer	6.6e-05	0.000351	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.59e-05	0.00035	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.59e-05	0.00035	CcSEcCtD
Meloxicam—Headache—Sorafenib—kidney cancer	6.59e-05	0.00035	CcSEcCtD
Meloxicam—Muscle spasms—Capecitabine—kidney cancer	6.57e-05	0.000349	CcSEcCtD
Meloxicam—Hyperhidrosis—Paclitaxel—kidney cancer	6.57e-05	0.000349	CcSEcCtD
Meloxicam—Diarrhoea—Dactinomycin—kidney cancer	6.56e-05	0.000349	CcSEcCtD
Meloxicam—Nasopharyngitis—Doxorubicin—kidney cancer	6.54e-05	0.000348	CcSEcCtD
Meloxicam—Gastritis—Doxorubicin—kidney cancer	6.48e-05	0.000344	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.45e-05	0.000343	CcSEcCtD
Meloxicam—Vision blurred—Capecitabine—kidney cancer	6.44e-05	0.000343	CcSEcCtD
Meloxicam—Vomiting—Sunitinib—kidney cancer	6.44e-05	0.000342	CcSEcCtD
Meloxicam—Body temperature increased—Gemcitabine—kidney cancer	6.42e-05	0.000341	CcSEcCtD
Meloxicam—Tremor—Capecitabine—kidney cancer	6.41e-05	0.000341	CcSEcCtD
Meloxicam—Rash—Sunitinib—kidney cancer	6.38e-05	0.000339	CcSEcCtD
Meloxicam—Dermatitis—Sunitinib—kidney cancer	6.38e-05	0.000339	CcSEcCtD
Meloxicam—Hypotension—Paclitaxel—kidney cancer	6.35e-05	0.000338	CcSEcCtD
Meloxicam—Ill-defined disorder—Capecitabine—kidney cancer	6.34e-05	0.000337	CcSEcCtD
Meloxicam—Headache—Sunitinib—kidney cancer	6.34e-05	0.000337	CcSEcCtD
Meloxicam—Influenza—Doxorubicin—kidney cancer	6.33e-05	0.000336	CcSEcCtD
Meloxicam—Asthma—Doxorubicin—kidney cancer	6.33e-05	0.000336	CcSEcCtD
Meloxicam—Anaemia—Capecitabine—kidney cancer	6.32e-05	0.000336	CcSEcCtD
Meloxicam—Hypersensitivity—Vincristine—kidney cancer	6.31e-05	0.000335	CcSEcCtD
Meloxicam—Nausea—Sorafenib—kidney cancer	6.25e-05	0.000332	CcSEcCtD
Meloxicam—Pancreatitis—Doxorubicin—kidney cancer	6.2e-05	0.00033	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.2e-05	0.000329	CcSEcCtD
Meloxicam—Malaise—Capecitabine—kidney cancer	6.17e-05	0.000328	CcSEcCtD
Meloxicam—Angina pectoris—Doxorubicin—kidney cancer	6.16e-05	0.000328	CcSEcCtD
Meloxicam—Insomnia—Paclitaxel—kidney cancer	6.15e-05	0.000327	CcSEcCtD
Meloxicam—Vertigo—Capecitabine—kidney cancer	6.14e-05	0.000327	CcSEcCtD
Meloxicam—Asthenia—Vincristine—kidney cancer	6.14e-05	0.000327	CcSEcCtD
Meloxicam—Syncope—Capecitabine—kidney cancer	6.13e-05	0.000326	CcSEcCtD
Meloxicam—Leukopenia—Capecitabine—kidney cancer	6.12e-05	0.000325	CcSEcCtD
Meloxicam—Paraesthesia—Paclitaxel—kidney cancer	6.11e-05	0.000325	CcSEcCtD
Meloxicam—Vomiting—Dactinomycin—kidney cancer	6.09e-05	0.000324	CcSEcCtD
Meloxicam—Bronchitis—Doxorubicin—kidney cancer	6.08e-05	0.000323	CcSEcCtD
Meloxicam—Dyspnoea—Paclitaxel—kidney cancer	6.06e-05	0.000322	CcSEcCtD
Meloxicam—Somnolence—Paclitaxel—kidney cancer	6.04e-05	0.000321	CcSEcCtD
Meloxicam—Palpitations—Capecitabine—kidney cancer	6.04e-05	0.000321	CcSEcCtD
Meloxicam—Rash—Dactinomycin—kidney cancer	6.04e-05	0.000321	CcSEcCtD
Meloxicam—Nausea—Sunitinib—kidney cancer	6.01e-05	0.00032	CcSEcCtD
Meloxicam—Loss of consciousness—Capecitabine—kidney cancer	6.01e-05	0.000319	CcSEcCtD
Meloxicam—Pancytopenia—Doxorubicin—kidney cancer	6.01e-05	0.000319	CcSEcCtD
Meloxicam—Dyspepsia—Paclitaxel—kidney cancer	5.99e-05	0.000318	CcSEcCtD
Meloxicam—Cough—Capecitabine—kidney cancer	5.97e-05	0.000317	CcSEcCtD
Meloxicam—Decreased appetite—Paclitaxel—kidney cancer	5.91e-05	0.000314	CcSEcCtD
Meloxicam—Hypertension—Capecitabine—kidney cancer	5.9e-05	0.000314	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Doxorubicin—kidney cancer	5.88e-05	0.000313	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.87e-05	0.000312	CcSEcCtD
Meloxicam—Fatigue—Paclitaxel—kidney cancer	5.86e-05	0.000312	CcSEcCtD
Meloxicam—Diarrhoea—Vincristine—kidney cancer	5.86e-05	0.000311	CcSEcCtD
Meloxicam—Pollakiuria—Doxorubicin—kidney cancer	5.84e-05	0.000311	CcSEcCtD
Meloxicam—Asthenia—Gemcitabine—kidney cancer	5.83e-05	0.00031	CcSEcCtD
Meloxicam—Arthralgia—Capecitabine—kidney cancer	5.82e-05	0.000309	CcSEcCtD
Meloxicam—Myalgia—Capecitabine—kidney cancer	5.82e-05	0.000309	CcSEcCtD
Meloxicam—Pain—Paclitaxel—kidney cancer	5.81e-05	0.000309	CcSEcCtD
Meloxicam—Constipation—Paclitaxel—kidney cancer	5.81e-05	0.000309	CcSEcCtD
Meloxicam—Anxiety—Capecitabine—kidney cancer	5.8e-05	0.000308	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.78e-05	0.000307	CcSEcCtD
Meloxicam—Photosensitivity reaction—Doxorubicin—kidney cancer	5.77e-05	0.000307	CcSEcCtD
Meloxicam—Weight increased—Doxorubicin—kidney cancer	5.76e-05	0.000306	CcSEcCtD
Meloxicam—Discomfort—Capecitabine—kidney cancer	5.75e-05	0.000306	CcSEcCtD
Meloxicam—Pruritus—Gemcitabine—kidney cancer	5.75e-05	0.000305	CcSEcCtD
Meloxicam—Weight decreased—Doxorubicin—kidney cancer	5.72e-05	0.000304	CcSEcCtD
Meloxicam—Dry mouth—Capecitabine—kidney cancer	5.69e-05	0.000303	CcSEcCtD
Meloxicam—Nausea—Dactinomycin—kidney cancer	5.69e-05	0.000303	CcSEcCtD
Meloxicam—Dizziness—Vincristine—kidney cancer	5.66e-05	0.000301	CcSEcCtD
Meloxicam—Drowsiness—Doxorubicin—kidney cancer	5.64e-05	0.0003	CcSEcCtD
Meloxicam—Infestation—Doxorubicin—kidney cancer	5.64e-05	0.0003	CcSEcCtD
Meloxicam—Infestation NOS—Doxorubicin—kidney cancer	5.64e-05	0.0003	CcSEcCtD
Meloxicam—Confusional state—Capecitabine—kidney cancer	5.63e-05	0.000299	CcSEcCtD
Meloxicam—Feeling abnormal—Paclitaxel—kidney cancer	5.6e-05	0.000298	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.59e-05	0.000297	CcSEcCtD
Meloxicam—Oedema—Capecitabine—kidney cancer	5.58e-05	0.000297	CcSEcCtD
Meloxicam—Gastrointestinal pain—Paclitaxel—kidney cancer	5.56e-05	0.000296	CcSEcCtD
Meloxicam—Diarrhoea—Gemcitabine—kidney cancer	5.56e-05	0.000295	CcSEcCtD
Meloxicam—Renal failure—Doxorubicin—kidney cancer	5.54e-05	0.000295	CcSEcCtD
Meloxicam—Infection—Capecitabine—kidney cancer	5.54e-05	0.000295	CcSEcCtD
Meloxicam—Jaundice—Doxorubicin—kidney cancer	5.5e-05	0.000292	CcSEcCtD
Meloxicam—Stomatitis—Doxorubicin—kidney cancer	5.5e-05	0.000292	CcSEcCtD
Meloxicam—Shock—Capecitabine—kidney cancer	5.49e-05	0.000292	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—kidney cancer	5.48e-05	0.000291	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—kidney cancer	5.48e-05	0.000291	CcSEcCtD
Meloxicam—Nervous system disorder—Capecitabine—kidney cancer	5.47e-05	0.000291	CcSEcCtD
Meloxicam—Thrombocytopenia—Capecitabine—kidney cancer	5.46e-05	0.00029	CcSEcCtD
Meloxicam—Tachycardia—Capecitabine—kidney cancer	5.45e-05	0.00029	CcSEcCtD
Meloxicam—Vomiting—Vincristine—kidney cancer	5.44e-05	0.000289	CcSEcCtD
Meloxicam—Skin disorder—Capecitabine—kidney cancer	5.42e-05	0.000288	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—kidney cancer	5.41e-05	0.000287	CcSEcCtD
Meloxicam—Urticaria—Paclitaxel—kidney cancer	5.4e-05	0.000287	CcSEcCtD
Meloxicam—Rash—Vincristine—kidney cancer	5.4e-05	0.000287	CcSEcCtD
Meloxicam—Hyperhidrosis—Capecitabine—kidney cancer	5.39e-05	0.000287	CcSEcCtD
Meloxicam—Dermatitis—Vincristine—kidney cancer	5.39e-05	0.000287	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—kidney cancer	5.38e-05	0.000286	CcSEcCtD
Meloxicam—Abdominal pain—Paclitaxel—kidney cancer	5.38e-05	0.000286	CcSEcCtD
Meloxicam—Body temperature increased—Paclitaxel—kidney cancer	5.38e-05	0.000286	CcSEcCtD
Meloxicam—Headache—Vincristine—kidney cancer	5.36e-05	0.000285	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—kidney cancer	5.33e-05	0.000284	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—kidney cancer	5.29e-05	0.000281	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—kidney cancer	5.26e-05	0.00028	CcSEcCtD
Meloxicam—Hypotension—Capecitabine—kidney cancer	5.21e-05	0.000277	CcSEcCtD
Meloxicam—Vomiting—Gemcitabine—kidney cancer	5.16e-05	0.000275	CcSEcCtD
Meloxicam—Rash—Gemcitabine—kidney cancer	5.12e-05	0.000272	CcSEcCtD
Meloxicam—Dermatitis—Gemcitabine—kidney cancer	5.12e-05	0.000272	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—kidney cancer	5.09e-05	0.000271	CcSEcCtD
Meloxicam—Headache—Gemcitabine—kidney cancer	5.09e-05	0.00027	CcSEcCtD
Meloxicam—Nausea—Vincristine—kidney cancer	5.09e-05	0.00027	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.08e-05	0.00027	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—kidney cancer	5.08e-05	0.00027	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—kidney cancer	5.06e-05	0.000269	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—kidney cancer	5.06e-05	0.000269	CcSEcCtD
Meloxicam—Insomnia—Capecitabine—kidney cancer	5.05e-05	0.000268	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—kidney cancer	5.02e-05	0.000267	CcSEcCtD
Meloxicam—Paraesthesia—Capecitabine—kidney cancer	5.01e-05	0.000266	CcSEcCtD
Meloxicam—Hypersensitivity—Paclitaxel—kidney cancer	5.01e-05	0.000266	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—kidney cancer	5e-05	0.000266	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—kidney cancer	4.99e-05	0.000265	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—kidney cancer	4.98e-05	0.000264	CcSEcCtD
Meloxicam—Dyspnoea—Capecitabine—kidney cancer	4.97e-05	0.000264	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—kidney cancer	4.96e-05	0.000264	CcSEcCtD
Meloxicam—Dyspepsia—Capecitabine—kidney cancer	4.91e-05	0.000261	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—kidney cancer	4.88e-05	0.000259	CcSEcCtD
Meloxicam—Asthenia—Paclitaxel—kidney cancer	4.88e-05	0.000259	CcSEcCtD
Meloxicam—Decreased appetite—Capecitabine—kidney cancer	4.85e-05	0.000258	CcSEcCtD
Meloxicam—Nausea—Gemcitabine—kidney cancer	4.82e-05	0.000256	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Capecitabine—kidney cancer	4.82e-05	0.000256	CcSEcCtD
Meloxicam—Fatigue—Capecitabine—kidney cancer	4.81e-05	0.000256	CcSEcCtD
Meloxicam—Pruritus—Paclitaxel—kidney cancer	4.81e-05	0.000256	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—kidney cancer	4.79e-05	0.000254	CcSEcCtD
Meloxicam—Pain—Capecitabine—kidney cancer	4.77e-05	0.000254	CcSEcCtD
Meloxicam—Constipation—Capecitabine—kidney cancer	4.77e-05	0.000254	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—kidney cancer	4.73e-05	0.000252	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—kidney cancer	4.72e-05	0.000251	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—kidney cancer	4.7e-05	0.00025	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—kidney cancer	4.7e-05	0.00025	CcSEcCtD
Meloxicam—Diarrhoea—Paclitaxel—kidney cancer	4.65e-05	0.000247	CcSEcCtD
Meloxicam—Feeling abnormal—Capecitabine—kidney cancer	4.6e-05	0.000244	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—kidney cancer	4.59e-05	0.000244	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—kidney cancer	4.57e-05	0.000243	CcSEcCtD
Meloxicam—Gastrointestinal pain—Capecitabine—kidney cancer	4.56e-05	0.000243	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—kidney cancer	4.56e-05	0.000243	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—kidney cancer	4.52e-05	0.00024	CcSEcCtD
Meloxicam—Dizziness—Paclitaxel—kidney cancer	4.5e-05	0.000239	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—kidney cancer	4.47e-05	0.000238	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—kidney cancer	4.44e-05	0.000236	CcSEcCtD
Meloxicam—Urticaria—Capecitabine—kidney cancer	4.43e-05	0.000236	CcSEcCtD
Meloxicam—Body temperature increased—Capecitabine—kidney cancer	4.41e-05	0.000235	CcSEcCtD
Meloxicam—Abdominal pain—Capecitabine—kidney cancer	4.41e-05	0.000235	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—kidney cancer	4.41e-05	0.000234	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—kidney cancer	4.41e-05	0.000234	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—kidney cancer	4.34e-05	0.000231	CcSEcCtD
Meloxicam—Tension—Doxorubicin—kidney cancer	4.32e-05	0.00023	CcSEcCtD
Meloxicam—Vomiting—Paclitaxel—kidney cancer	4.32e-05	0.00023	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—kidney cancer	4.32e-05	0.000229	CcSEcCtD
Meloxicam—Rash—Paclitaxel—kidney cancer	4.29e-05	0.000228	CcSEcCtD
Meloxicam—Dermatitis—Paclitaxel—kidney cancer	4.28e-05	0.000228	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—kidney cancer	4.28e-05	0.000228	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—kidney cancer	4.26e-05	0.000227	CcSEcCtD
Meloxicam—Headache—Paclitaxel—kidney cancer	4.26e-05	0.000226	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—kidney cancer	4.24e-05	0.000225	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—kidney cancer	4.15e-05	0.000221	CcSEcCtD
Meloxicam—Hypersensitivity—Capecitabine—kidney cancer	4.11e-05	0.000219	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—kidney cancer	4.09e-05	0.000217	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—kidney cancer	4.07e-05	0.000217	CcSEcCtD
Meloxicam—Nausea—Paclitaxel—kidney cancer	4.04e-05	0.000215	CcSEcCtD
Meloxicam—Asthenia—Capecitabine—kidney cancer	4e-05	0.000213	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—kidney cancer	3.97e-05	0.000211	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—kidney cancer	3.96e-05	0.000211	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—kidney cancer	3.95e-05	0.00021	CcSEcCtD
Meloxicam—Pruritus—Capecitabine—kidney cancer	3.95e-05	0.00021	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—kidney cancer	3.95e-05	0.00021	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—kidney cancer	3.89e-05	0.000207	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—kidney cancer	3.87e-05	0.000206	CcSEcCtD
Meloxicam—Cough—Doxorubicin—kidney cancer	3.85e-05	0.000204	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—kidney cancer	3.82e-05	0.000203	CcSEcCtD
Meloxicam—Diarrhoea—Capecitabine—kidney cancer	3.82e-05	0.000203	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—kidney cancer	3.81e-05	0.000202	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—kidney cancer	3.75e-05	0.000199	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—kidney cancer	3.75e-05	0.000199	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—kidney cancer	3.74e-05	0.000199	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.73e-05	0.000198	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—kidney cancer	3.71e-05	0.000197	CcSEcCtD
Meloxicam—Dizziness—Capecitabine—kidney cancer	3.69e-05	0.000196	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—kidney cancer	3.67e-05	0.000195	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—kidney cancer	3.63e-05	0.000193	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—kidney cancer	3.6e-05	0.000191	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—kidney cancer	3.6e-05	0.000191	CcSEcCtD
Meloxicam—Infection—Doxorubicin—kidney cancer	3.57e-05	0.00019	CcSEcCtD
Meloxicam—Vomiting—Capecitabine—kidney cancer	3.55e-05	0.000189	CcSEcCtD
Meloxicam—Shock—Doxorubicin—kidney cancer	3.54e-05	0.000188	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—kidney cancer	3.53e-05	0.000188	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—kidney cancer	3.52e-05	0.000187	CcSEcCtD
Meloxicam—Rash—Capecitabine—kidney cancer	3.52e-05	0.000187	CcSEcCtD
Meloxicam—Dermatitis—Capecitabine—kidney cancer	3.52e-05	0.000187	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—kidney cancer	3.51e-05	0.000187	CcSEcCtD
Meloxicam—Headache—Capecitabine—kidney cancer	3.5e-05	0.000186	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—kidney cancer	3.49e-05	0.000186	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—kidney cancer	3.48e-05	0.000185	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—kidney cancer	3.36e-05	0.000179	CcSEcCtD
Meloxicam—Nausea—Capecitabine—kidney cancer	3.31e-05	0.000176	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.28e-05	0.000174	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—kidney cancer	3.25e-05	0.000173	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—kidney cancer	3.23e-05	0.000172	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—kidney cancer	3.21e-05	0.00017	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—kidney cancer	3.2e-05	0.00017	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—kidney cancer	3.17e-05	0.000168	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—kidney cancer	3.13e-05	0.000166	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.11e-05	0.000165	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—kidney cancer	3.1e-05	0.000165	CcSEcCtD
Meloxicam—Pain—Doxorubicin—kidney cancer	3.08e-05	0.000164	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—kidney cancer	3.08e-05	0.000164	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—kidney cancer	2.96e-05	0.000158	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—kidney cancer	2.94e-05	0.000156	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—kidney cancer	2.86e-05	0.000152	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—kidney cancer	2.84e-05	0.000151	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—kidney cancer	2.84e-05	0.000151	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—kidney cancer	2.65e-05	0.000141	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—kidney cancer	2.58e-05	0.000137	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—kidney cancer	2.54e-05	0.000135	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—kidney cancer	2.46e-05	0.000131	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—kidney cancer	2.38e-05	0.000126	CcSEcCtD
Meloxicam—PTGS2—Metabolism—FH—kidney cancer	2.33e-05	0.000558	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.33e-05	0.000557	CbGpPWpGaD
Meloxicam—PGD—Disease—RAF1—kidney cancer	2.32e-05	0.000555	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.3e-05	0.000551	CbGpPWpGaD
Meloxicam—PGD—Disease—ERBB2—kidney cancer	2.3e-05	0.000549	CbGpPWpGaD
Meloxicam—Vomiting—Doxorubicin—kidney cancer	2.29e-05	0.000122	CcSEcCtD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.28e-05	0.000546	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC5A3—kidney cancer	2.27e-05	0.000543	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PGK1—kidney cancer	2.27e-05	0.000543	CbGpPWpGaD
Meloxicam—Rash—Doxorubicin—kidney cancer	2.27e-05	0.000121	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—kidney cancer	2.27e-05	0.00012	CcSEcCtD
Meloxicam—PGD—Disease—MTOR—kidney cancer	2.27e-05	0.000542	CbGpPWpGaD
Meloxicam—PGD—Disease—CD4—kidney cancer	2.26e-05	0.000541	CbGpPWpGaD
Meloxicam—Headache—Doxorubicin—kidney cancer	2.25e-05	0.00012	CcSEcCtD
Meloxicam—PGD—Disease—PTGS2—kidney cancer	2.24e-05	0.000537	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LDHB—kidney cancer	2.23e-05	0.000533	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SFRP2—kidney cancer	2.23e-05	0.000533	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.2e-05	0.000527	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPC3—kidney cancer	2.19e-05	0.000525	CbGpPWpGaD
Meloxicam—Nausea—Doxorubicin—kidney cancer	2.14e-05	0.000114	CcSEcCtD
Meloxicam—PTGS2—Metabolism—CA2—kidney cancer	2.13e-05	0.000511	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.13e-05	0.00051	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.13e-05	0.00051	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN1B—kidney cancer	2.13e-05	0.000509	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALAD—kidney cancer	2.08e-05	0.000498	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TCEB2—kidney cancer	2.08e-05	0.000497	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TCEB1—kidney cancer	2.08e-05	0.000497	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.06e-05	0.000494	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.04e-05	0.000489	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPAT—kidney cancer	2.04e-05	0.000489	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.04e-05	0.000489	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PDHB—kidney cancer	2.04e-05	0.000488	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CA9—kidney cancer	2.04e-05	0.000487	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.03e-05	0.000487	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.03e-05	0.000487	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—POMC—kidney cancer	2.03e-05	0.000486	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.03e-05	0.000486	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.03e-05	0.000486	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.02e-05	0.000482	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.01e-05	0.000482	CbGpPWpGaD
Meloxicam—PGD—Disease—CTNNB1—kidney cancer	2.01e-05	0.000481	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2e-05	0.000478	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.99e-05	0.000476	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDH1A1—kidney cancer	1.98e-05	0.000475	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—kidney cancer	1.97e-05	0.000471	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.96e-05	0.00047	CbGpPWpGaD
Meloxicam—PGD—Disease—PTEN—kidney cancer	1.96e-05	0.000468	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CCBL1—kidney cancer	1.92e-05	0.000459	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—RAF1—kidney cancer	1.91e-05	0.000457	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PGK1—kidney cancer	1.9e-05	0.000455	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC5A3—kidney cancer	1.9e-05	0.000455	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APRT—kidney cancer	1.9e-05	0.000454	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FH—kidney cancer	1.9e-05	0.000454	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.9e-05	0.000454	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—kidney cancer	1.88e-05	0.00045	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.87e-05	0.000448	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—LDHB—kidney cancer	1.86e-05	0.000446	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.85e-05	0.000444	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.8e-05	0.00043	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPC3—kidney cancer	1.78e-05	0.000427	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.77e-05	0.000424	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.77e-05	0.000424	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA2—kidney cancer	1.74e-05	0.000415	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.73e-05	0.000415	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CRABP1—kidney cancer	1.73e-05	0.000414	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—kidney cancer	1.71e-05	0.000409	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALAD—kidney cancer	1.69e-05	0.000405	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RPL14—kidney cancer	1.69e-05	0.000404	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.68e-05	0.000401	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK3—kidney cancer	1.67e-05	0.0004	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPAT—kidney cancer	1.66e-05	0.000398	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.66e-05	0.000398	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.65e-05	0.000395	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.65e-05	0.000395	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.64e-05	0.000393	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTEN—kidney cancer	1.64e-05	0.000392	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.63e-05	0.00039	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—kidney cancer	1.63e-05	0.000389	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.62e-05	0.000389	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA9—kidney cancer	1.62e-05	0.000387	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.61e-05	0.000386	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ITPR2—kidney cancer	1.61e-05	0.000385	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.6e-05	0.000382	CbGpPWpGaD
Meloxicam—PGD—Disease—MAPK1—kidney cancer	1.59e-05	0.000381	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACY1—kidney cancer	1.58e-05	0.000378	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.58e-05	0.000378	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PGK1—kidney cancer	1.55e-05	0.00037	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.55e-05	0.00037	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APRT—kidney cancer	1.54e-05	0.00037	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FH—kidney cancer	1.54e-05	0.00037	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ITPR2—kidney cancer	1.53e-05	0.000365	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LDHB—kidney cancer	1.52e-05	0.000363	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.51e-05	0.000361	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.51e-05	0.000361	CbGpPWpGaD
Meloxicam—PGD—Disease—KRAS—kidney cancer	1.5e-05	0.00036	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.48e-05	0.000355	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTT1—kidney cancer	1.47e-05	0.000351	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ACHE—kidney cancer	1.47e-05	0.000351	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—kidney cancer	1.45e-05	0.000348	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPC3—kidney cancer	1.45e-05	0.000348	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA2—kidney cancer	1.41e-05	0.000338	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SCARB1—kidney cancer	1.39e-05	0.000333	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.38e-05	0.000331	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—kidney cancer	1.38e-05	0.00033	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALAD—kidney cancer	1.38e-05	0.00033	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK3—kidney cancer	1.38e-05	0.000329	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CRABP1—kidney cancer	1.37e-05	0.000329	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSMD7—kidney cancer	1.35e-05	0.000323	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PDHB—kidney cancer	1.34e-05	0.000322	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.34e-05	0.000322	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—POMC—kidney cancer	1.34e-05	0.000321	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.34e-05	0.000321	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA9—kidney cancer	1.32e-05	0.000315	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.31e-05	0.000314	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MAPK1—kidney cancer	1.31e-05	0.000313	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.29e-05	0.000308	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—BCHE—kidney cancer	1.28e-05	0.000306	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSMD7—kidney cancer	1.28e-05	0.000306	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ITPR2—kidney cancer	1.28e-05	0.000306	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CCBL1—kidney cancer	1.26e-05	0.000302	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC5A5—kidney cancer	1.26e-05	0.000302	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.26e-05	0.000301	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PGK1—kidney cancer	1.26e-05	0.000301	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—KRAS—kidney cancer	1.24e-05	0.000296	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LDHB—kidney cancer	1.23e-05	0.000296	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC2A1—kidney cancer	1.22e-05	0.000292	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.18e-05	0.000283	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.18e-05	0.000282	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTT1—kidney cancer	1.17e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ACHE—kidney cancer	1.17e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC2A1—kidney cancer	1.16e-05	0.000277	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—kidney cancer	1.16e-05	0.000277	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JUNB—kidney cancer	1.15e-05	0.000275	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.14e-05	0.000272	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CRABP1—kidney cancer	1.12e-05	0.000268	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SCARB1—kidney cancer	1.1e-05	0.000264	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—kidney cancer	1.1e-05	0.000263	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.1e-05	0.000262	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPAT—kidney cancer	1.1e-05	0.000262	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTGS1—kidney cancer	1.09e-05	0.000261	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSMD7—kidney cancer	1.07e-05	0.000256	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA9—kidney cancer	1.07e-05	0.000256	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.05e-05	0.00025	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ITPR2—kidney cancer	1.04e-05	0.000249	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.03e-05	0.000247	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APRT—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FH—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTP1—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—BCHE—kidney cancer	1.02e-05	0.000243	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC5A5—kidney cancer	1e-05	0.00024	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC2A1—kidney cancer	9.69e-06	0.000232	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—kidney cancer	9.63e-06	0.000231	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.59e-06	0.000229	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPC3—kidney cancer	9.58e-06	0.000229	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ACHE—kidney cancer	9.48e-06	0.000227	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTT1—kidney cancer	9.48e-06	0.000227	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—kidney cancer	9.35e-06	0.000224	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN2B—kidney cancer	9.35e-06	0.000224	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA2—kidney cancer	9.32e-06	0.000223	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CRABP1—kidney cancer	9.1e-06	0.000218	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALAD—kidney cancer	9.08e-06	0.000217	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SCARB1—kidney cancer	8.98e-06	0.000215	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS1—kidney cancer	8.89e-06	0.000213	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1A1—kidney cancer	8.86e-06	0.000212	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.86e-06	0.000212	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSMD7—kidney cancer	8.71e-06	0.000209	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.66e-06	0.000207	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ITPR2—kidney cancer	8.46e-06	0.000203	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PGK1—kidney cancer	8.3e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.3e-06	0.000199	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BCHE—kidney cancer	8.26e-06	0.000198	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.2e-06	0.000196	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.16e-06	0.000195	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LDHB—kidney cancer	8.14e-06	0.000195	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTP1—kidney cancer	8.08e-06	0.000193	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.88e-06	0.000189	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.8e-06	0.000187	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTT1—kidney cancer	7.72e-06	0.000185	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ACHE—kidney cancer	7.72e-06	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—kidney cancer	7.65e-06	0.000183	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.65e-06	0.000183	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIF1A—kidney cancer	7.47e-06	0.000179	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TSC2—kidney cancer	7.45e-06	0.000178	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—kidney cancer	7.42e-06	0.000178	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SCARB1—kidney cancer	7.31e-06	0.000175	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.28e-06	0.000174	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS1—kidney cancer	7.23e-06	0.000173	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSMD7—kidney cancer	7.09e-06	0.00017	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA9—kidney cancer	7.06e-06	0.000169	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A1—kidney cancer	7.04e-06	0.000168	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BCHE—kidney cancer	6.72e-06	0.000161	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.67e-06	0.00016	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.64e-06	0.000159	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—POMC—kidney cancer	6.61e-06	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KIT—kidney cancer	6.58e-06	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—kidney cancer	6.58e-06	0.000158	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTP1—kidney cancer	6.57e-06	0.000157	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.41e-06	0.000154	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.22e-06	0.000149	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—kidney cancer	6.22e-06	0.000149	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BRAF—kidney cancer	6.19e-06	0.000148	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—kidney cancer	6.04e-06	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CRABP1—kidney cancer	6e-06	0.000144	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.78e-06	0.000138	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.73e-06	0.000137	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ITPR2—kidney cancer	5.58e-06	0.000134	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.43e-06	0.00013	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTP1—kidney cancer	5.35e-06	0.000128	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—kidney cancer	5.27e-06	0.000126	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—POMC—kidney cancer	5.25e-06	0.000126	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RAF1—kidney cancer	5.17e-06	0.000124	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—kidney cancer	5.11e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACHE—kidney cancer	5.09e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTT1—kidney cancer	5.09e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—kidney cancer	5.06e-06	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTOR—kidney cancer	5.04e-06	0.000121	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—kidney cancer	5.03e-06	0.00012	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—kidney cancer	4.92e-06	0.000118	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SCARB1—kidney cancer	4.82e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS1—kidney cancer	4.77e-06	0.000114	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—kidney cancer	4.73e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.7e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSMD7—kidney cancer	4.68e-06	0.000112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.66e-06	0.000112	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTEN—kidney cancer	4.6e-06	0.00011	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CTNNB1—kidney cancer	4.47e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BCHE—kidney cancer	4.43e-06	0.000106	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.38e-06	0.000105	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PTEN—kidney cancer	4.36e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—POMC—kidney cancer	4.27e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.23e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.83e-06	9.16e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK3—kidney cancer	3.72e-06	8.91e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTEN—kidney cancer	3.65e-06	8.74e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—kidney cancer	3.62e-06	8.67e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MAPK1—kidney cancer	3.54e-06	8.48e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTP1—kidney cancer	3.53e-06	8.44e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—POMC—kidney cancer	3.47e-06	8.32e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—kidney cancer	3.41e-06	8.15e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—kidney cancer	3.35e-06	8.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—kidney cancer	3.34e-06	7.99e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—kidney cancer	3.24e-06	7.76e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—kidney cancer	3.24e-06	7.76e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—kidney cancer	3.07e-06	7.36e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.07e-06	7.36e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTEN—kidney cancer	2.97e-06	7.11e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—kidney cancer	2.77e-06	6.63e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—kidney cancer	2.57e-06	6.16e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTEN—kidney cancer	2.42e-06	5.78e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—POMC—kidney cancer	2.29e-06	5.48e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.1e-06	5.01e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—kidney cancer	1.83e-06	4.37e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.71e-06	4.08e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTEN—kidney cancer	1.59e-06	3.82e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.12e-06	2.69e-05	CbGpPWpGaD
